Beyond the typical path from concept through to investigational new drug application (“IND”) for a new topical or transdermal drug product intended for a 505(b)(2) regulatory submission outlined in our main offerings, Tioga Research has capabilities to support clients also in a range of other ways, including:
Other Services
New high throughput experimentation (“HTE”) technologies for discovery and screening
Conceptualization, prototyping, implementation and validation of conventional and HTE platforms for screening membrane permeabilization and permeation, with a particular emphasis on replicating the fidelity of conventional techniques, yet achieving throughput gains of 2-120 fold
R&D of Generic Drug Products
Reverse engineering of a current or prospective product, using analytical methods to ascertain, or literature research, to infer formulation composition; replication of an innovator composition; devising and verifying novel compositions that offer freedom to operate by circumventing patent claims
Screening delivery of cosmeceuticals
Measurements of delivery of a cosmeceutical active into the skin compartments and through the skin
